Literature DB >> 17533421

Combined pharmacological block of I(Kr) and I(Ks) increases short-term QT interval variability and provokes torsades de pointes.

C Lengyel1, A Varró, K Tábori, J G Papp, I Baczkó.   

Abstract

BACKGROUND AND
PURPOSE: Assessing the proarrhythmic potential of compounds during drug development is essential. However, reliable prediction of drug-induced torsades de pointes arrhythmia (TdP) remains elusive. Along with QT interval prolongation, assessment of the short-term variability of the QT interval (STV(QT)) may be a good predictor of TdP. We investigated the relative importance of I(Ks) and I(Kr) block in development of TdP together with correlations between QTc interval, QT interval variability and incidence of TdP. EXPERIMENTAL APPROACH: ECGs were recorded from conscious dogs and from anaesthetized rabbits given the I(Kr) blocker dofetilide (DOF), the I(Ks) blocker HMR-1556 (HMR) and their combination, intravenously. PQ, RR and QT intervals were measured and QTc and short-term variability of RR and QT intervals calculated. KEY
RESULTS: DOF increased QTc interval by 20% in dogs and 8% in rabbits. HMR increased QTc in dogs by 12 and 1.9% in rabbits. Combination of DOF+HMR prolonged QTc by 33% in dogs, by 16% in rabbits. DOF or HMR given alone in dogs or HMR given alone in rabbits induced no TdP. Incidence of TdP increased after DOF+HMR combinations in dogs (63%) and following HMR+DOF (82%) and DOF+HMR combinations (71%) in rabbits. STV(QT) markedly increased only after administration of DOF+HMR combinations in both dogs and rabbits. CONCLUSION AND IMPLICATIONS: STV(QT) was markedly increased by combined pharmacological block of I(Kr) and I(Ks) and may be a better predictor of subsequent TdP development than the measurement of QTc interval prolongation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17533421      PMCID: PMC2042930          DOI: 10.1038/sj.bjp.0707297

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

1.  Do existing measures of Poincaré plot geometry reflect nonlinear features of heart rate variability?

Authors:  M Brennan; M Palaniswami; P Kamen
Journal:  IEEE Trans Biomed Eng       Date:  2001-11       Impact factor: 4.538

2.  Limited induction of torsade de pointes by terikalant and erythromycin in an in vivo model.

Authors:  András Farkas; Susan J Coker
Journal:  Eur J Pharmacol       Date:  2002-08-02       Impact factor: 4.432

3.  Downregulation of delayed rectifier K(+) currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes.

Authors:  P G Volders; K R Sipido; M A Vos; R L Spätjens; J D Leunissen; E Carmeliet; H J Wellens
Journal:  Circulation       Date:  1999-12-14       Impact factor: 29.690

4.  Pharmacological block of the slow component of the outward delayed rectifier current (I(Ks)) fails to lengthen rabbit ventricular muscle QT(c) and action potential duration.

Authors:  C Lengyel; N Iost; L Virág; A Varró; D A Lathrop; J G Papp
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

5.  Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome.

Authors:  J M van Opstal; M Schoenmakers; S C Verduyn; S H de Groot; J D Leunissen; F F van Der Hulst; M M Molenschot; H J Wellens; M A Vos
Journal:  Circulation       Date:  2001-11-27       Impact factor: 29.690

6.  Inhibition of IKs channels by HMR 1556.

Authors:  H Gögelein; A Brüggemann; U Gerlach; J Brendel; A E Busch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-12       Impact factor: 3.000

7.  The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization.

Authors:  A Varro; B Baláti; N Iost; J Takács; L Virág; D A Lathrop; L Csaba; L Tálosi; J G Papp
Journal:  J Physiol       Date:  2000-02-15       Impact factor: 5.182

8.  Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of torsade de pointes.

Authors:  Andrew J Batey; Susan J Coker
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

9.  Phase 2 prolongation, in the absence of instability and triangulation, antagonizes class III proarrhythmia.

Authors:  L M Hondeghem; K Dujardin; F De Clerck
Journal:  Cardiovasc Res       Date:  2001-05       Impact factor: 10.787

10.  HMR 1556, a potent and selective blocker of slowly activating delayed rectifier potassium current.

Authors:  George P Thomas; Uwe Gerlach; Charles Antzelevitch
Journal:  J Cardiovasc Pharmacol       Date:  2003-01       Impact factor: 3.105

View more
  38 in total

Review 1.  Drug-induced long QT syndrome.

Authors:  Prince Kannankeril; Dan M Roden; Dawood Darbar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Double pharmacological challenge on repolarization opens new avenues for drug safety research.

Authors:  M B Thomsen
Journal:  Br J Pharmacol       Date:  2007-06-04       Impact factor: 8.739

3.  Relation between beat-to-beat QT interval variability and T-wave amplitude in healthy subjects.

Authors:  Muhammad A Hasan; Derek Abbott; Mathias Baumert
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-07       Impact factor: 1.468

4.  Ca2+-activated Cl- current is antiarrhythmic by reducing both spatial and temporal heterogeneity of cardiac repolarization.

Authors:  Bence Hegyi; Balázs Horváth; Krisztina Váczi; Mónika Gönczi; Kornél Kistamás; Ferenc Ruzsnavszky; Roland Veress; Leighton T Izu; Ye Chen-Izu; Tamás Bányász; János Magyar; László Csernoch; Péter P Nánási; Norbert Szentandrássy
Journal:  J Mol Cell Cardiol       Date:  2017-06-29       Impact factor: 5.000

5.  Contribution of ion currents to beat-to-beat variability of action potential duration in canine ventricular myocytes.

Authors:  Norbert Szentandrássy; Kornél Kistamás; Bence Hegyi; Balázs Horváth; Ferenc Ruzsnavszky; Krisztina Váczi; János Magyar; Tamás Bányász; András Varró; Péter P Nánási
Journal:  Pflugers Arch       Date:  2014-08-02       Impact factor: 3.657

6.  Electrophysiological studies of transgenic long QT type 1 and type 2 rabbits reveal genotype-specific differences in ventricular refractoriness and His conduction.

Authors:  Katja E Odening; Malcolm Kirk; Michael Brunner; Ohad Ziv; Peem Lorvidhaya; Gong Xin Liu; Lorraine Schofield; Leonard Chaves; Xuwen Peng; Manfred Zehender; Bum-Rak Choi; Gideon Koren
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-06-25       Impact factor: 4.733

7.  Slow Delayed Rectifier Current Protects Ventricular Myocytes From Arrhythmic Dynamics Across Multiple Species: A Computational Study.

Authors:  Meera Varshneya; Ryan A Devenyi; Eric A Sobie
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-10

8.  Variability of action potential duration in pharmacologically induced long QT syndrome type 1.

Authors:  Caroline L Ring; Salim F Idriss; Wanda Krassowska Neu
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

9.  Importance of vagally mediated bradycardia for the induction of torsade de pointes in an in vivo model.

Authors:  A Farkas; J Dempster; S J Coker
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

10.  Potentiation of E-4031-induced torsade de pointes by HMR1556 or ATX-II is not predicted by action potential short-term variability or triangulation.

Authors:  G Michael; J Dempster; K A Kane; S J Coker
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.